Navigation Links
IsZo Capital Writes to Special Committee of Taro Pharmaceutical Opposing Sun Pharmaceutical Offer and Liability Protection Management Proposals
Date:11/30/2011

NEW YORK, Nov. 30, 2011 /PRNewswire/ -- IsZo Capital Management LP, one of the largest minority shareholders of Taro Pharmaceutical Industries Ltd. (Pink Sheets: TAROF), announced today that it delivered the following letter to the Special Committee of the Board of Directors of Taro demanding that it reject the proposal made by Sun Pharmaceutical Industries Ltd. on October 18, 2011 to acquire the remaining outstanding shares of Taro for $24.5 per share.

November 29, 2011

Board of Directors
Taro Pharmaceutical Industries Ltd.
Euro Park (Italy Building)
Yakum Business Park, Yakum 60972, Israel

Attention:

Dilip Shanghvi, Chairman of the Board

 

Dan Biran, Chairman of the Audit Committee

 

Members of the Special Committee Evaluating Sun Acquisition Proposal

Dear Members of the Board, Audit Committee and Special Committee:

IsZo Capital LP is one of the largest minority shareholders of Taro Pharmaceutical Industries, if not the largest, and has been a shareholder for many years. We are writing to you as a concerned minority shareholder to demand that you exercise your fiduciary duties to us, and to similarly situated minority shareholders, and reject the Sun Pharmaceutical Industries acquisition proposal as the offer price is grossly inadequate, substantially undervalues Taro and is not in the best interests of Taro and the minority shareholders of Taro.

For the reasons set forth below, our stake in Taro is not for sale at this time. Like Sun, IsZo Capital prefers to retain its shares and realize the true value of the company instead of giving away our shares to Sun at the egregiously low price offered.

Rather than expending needed time and energy on Sun's below-mar
'/>"/>

SOURCE IsZo Capital Management LP
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Radient Pharmaceuticals Corporation Completes Restructurings with Institutional Investors to Limit Conversions and Stock Sales and Provide for Potential Additional Capital
2. Alacrita Launches Charity Auction of Executive One-to One Lunches with Senior Figures from the Pharmaceutical and Venture Capital Industries
3. Machine Solutions Inc. Partners With Forsyth Capital Investors, LLC
4. Insmed to Present at Lazard Capital Markets 8th Annual Healthcare Conference
5. Quest Diagnostics to Speak at the Lazard Capital Markets 8th Annual Healthcare Conference
6. Keryx Biopharmaceuticals to Present at Lazard Capital Markets 8th Annual Healthcare Conference
7. Accuray Incorporateds CEO to Speak at Lazard Capital Markets 8th Annual Healthcare Conference and Stephens Fall Investment Conference
8. HeartWare to Present at the Lazard Capital Markets 8th Annual Healthcare Conference
9. Oxford Finance Provides $3 Million Growth Capital Loan to Avantis Medical Systems
10. BioSpecifics Technologies Corp. to Present at Lazard Capital Markets 8th Annual Healthcare Conference
11. LCA-Vision to Present at the Lazard Capital Markets 8th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Shire plc (LSE: SHP, NASDAQ: ... of Fair Trading (OFT) approval condition to the announced tender ... (NASDAQ: VPHM).   As a result of the ... and Shire expects to complete the tender offer on January ... the satisfaction of all of the remaining conditions to the ...
(Date:1/15/2014)... 15, 2014  Manufacturers, suppliers and distributors ... be able to protect their most important ... (Logo: http://photos.prnewswire.com/prnh/20130716/CL46586LOGO ) ... Medical Device Industry, it steadfastly remains one ... cases involving IP infringement. This litigious nature ...
(Date:1/15/2014)... MultiCell Technologies, Inc. (OTC Bulletin Board: ... application concerning composition of matter, biological targets, mechanism of ... death.  This patent application describes a ... molecules (VSRNAs) which interfere with the basic homeostatic cellular ... less than 10 bps, yet are surprisingly capable in ...
Breaking Medicine Technology:Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3Intellectual Property Insurance for Medical-related Products and Services 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3
... Nasdaq: NVGN ), announced today that following ... held on 7 May, 2012, its Board of Directors ... Marshall Edwards, Inc. ("MEI") under the MEI rights offering ... rights that have not been otherwise exercised by MEI ...
... 2012  Marshall Edwards, Inc. (Nasdaq: MSHL ), ... novel therapeutics targeting cancer metabolism, announced that its majority ... million of Units, subject to availability, in Marshall Edwards, ... Novogen stockholders in Sydney on Monday. Pursuant ...
Cached Medicine Technology:Novogen Board Approves US$4 Million Investment In Marshall Edwards Rights Offering 2Marshall Edwards Receives $4 Million Subscription From Novogen In Rights Offering 2Marshall Edwards Receives $4 Million Subscription From Novogen In Rights Offering 3
(Date:4/14/2014)... orphaned by HIV/AIDS in South Africa may provide insight ... behavior issues in other areas of the world, which ... that could lead to successful interventions. , A ... United Nations mentions that due to the HIV/AIDS pandemic, ... African, children are at an increased risk for mental ...
(Date:4/14/2014)... A new study shows that moderate to severe ... risk of stroke, cancer and death. , Results of ... to severe obstructive sleep apnea were four times more ... times more likely to have a stroke (HR = ... (HR = 3.4), and 2.5 times more likely to ...
(Date:4/14/2014)... Dallas study involving serious youth offenders, the answer to one ... seven years: "How long do you think you,ll live?", According ... offending over time., Author Dr. Alex Piquero said the study ... of them offend at very high rates and commit more ... much later in life offend much less., "In a lot ...
(Date:4/14/2014)... with symptoms increasing dramatically during some of the most important ... has found. , Depressive symptoms increased on average by 68 ... young men, who were around 25 years old when they ... their children. The results of the study were published April ... is the first to identify when young fathers are at ...
(Date:4/14/2014)... Lower weight babies and babies who aren,t breastfed ... risk of developing chronic inflammation and related health ... study. , "There were good reasons to hypothesize ... inflammation in adulthood," says Thomas McDade (Northwestern University), ... in the Child & Brain Development program. "It ...
Breaking Medicine News(10 mins):Health News:Researchers identify children with emotional behavior difficulties 2Health News:Researchers identify children with emotional behavior difficulties 3Health News:Study links severe sleep apnea to increased risk of stroke, cancer and death 2Health News:UT Dallas study: Youth who fail to envision future commit more crimes 2Health News:Young dads at high risk of depression, too 2Health News:Low birth weight, less breastfeeding create later health risks 2
... Voters in New Television Ad, SACRAMENTO, Calif., Oct. ... a new television spot featuring Senator Diane Feinstein,who, speaking ... terrible mistake for California. It,s about discrimination and we ... moved to have the strong, trusted and independent voice ...
... drug delayed disease progression, researchers found , , WEDNESDAY, Oct. ... to treat erectile dysfunction, appears effective in treating pulmonary ... high blood pressure in the arteries that supply the ... can become tired, dizzy and short of breath, because ...
... BIRMINGHAM, Ala. and NASHVILLE, Tenn., Oct. 28 /PRNewswire-FirstCall/,-- ... that the PICA Group,will become part of ProAssurance ... Group (PICA) is the nation,s leading provider of ... 9,800,podiatric physicians in 47 states and the District ...
... 28 Align,Technology, Inc. (Nasdaq: ALGN ) today reported ... 30, 2008., Total net revenues for the third quarter ... million reported in the third quarter of,2007 (Q3 07) and ... (Q2 08)., On a generally accepted accounting principles (GAAP) ...
... Oct. 28 Blue Mountain Quality,Resources, Inc. ... Mountain Regulatory Asset Manager(R) to satisfy their ... of their enterprise-wide,SAP(R) implementation., "Alexion is ... productivity in,its manufacturing facilities and other operations," ...
... New Findings Suggest Soy Isoflavones Contribute to Blood Vessels, Healthy ... ... study examines how a certain,naturally-occurring component of soy may enhance the function ... to,the Center for Disease Control and Prevention, heart disease is the,nation,s number ...
Cached Medicine News:Health News:Cialis May Help Ease Pulmonary Hypertension 2Health News:The PICA Group Will Become Part of ProAssurance 2Health News:The PICA Group Will Become Part of ProAssurance 3Health News:The PICA Group Will Become Part of ProAssurance 4Health News:The PICA Group Will Become Part of ProAssurance 5Health News:The PICA Group Will Become Part of ProAssurance 6Health News:The PICA Group Will Become Part of ProAssurance 7Health News:The PICA Group Will Become Part of ProAssurance 8Health News:Align Technology Announces Third Quarter Fiscal 2008 Results 2Health News:Align Technology Announces Third Quarter Fiscal 2008 Results 3Health News:Align Technology Announces Third Quarter Fiscal 2008 Results 4Health News:Align Technology Announces Third Quarter Fiscal 2008 Results 5Health News:Align Technology Announces Third Quarter Fiscal 2008 Results 6Health News:Align Technology Announces Third Quarter Fiscal 2008 Results 7Health News:Align Technology Announces Third Quarter Fiscal 2008 Results 8Health News:Align Technology Announces Third Quarter Fiscal 2008 Results 9Health News:Align Technology Announces Third Quarter Fiscal 2008 Results 10Health News:Align Technology Announces Third Quarter Fiscal 2008 Results 11Health News:Align Technology Announces Third Quarter Fiscal 2008 Results 12Health News:Align Technology Announces Third Quarter Fiscal 2008 Results 13Health News:Align Technology Announces Third Quarter Fiscal 2008 Results 14Health News:Alexion Pharmaceuticals Chooses Blue Mountain Regulatory Asset Manager(R) for Best-in-class Calibration Management Integrated with SAP(R) 2Health News:Study Shows How Soy Compound Lowers Blood Pressure and Stroke Risk 2
For the quantitative determination of total cholesterol in human serum....
Intended for the quantitative determination of total cholesterol in serum. Single vial, dry powder reagent. Reaction: Endpoint. Wavelength: 500 nm. Linearity: 700 mg/dL (12.9 mmol/L)....
For the quantitative in vitro determination of lithium in serum and plasma. Wavelength: 550 nm. Linear range: up to 4 mm....
This True 12-bit integrated and cooled system is a completely self contained unit built with a long list of standard features including all-electronic-variable transilluminator and EPI lighting....
Medicine Products: